PAM-1616, a selective peroxisome proliferator-activated receptor ? modulator with preserved anti-diabetic efficacy and reduced adverse effects.

Source:http://linkedlifedata.com/resource/pubmed/id/20974124

Eur. J. Pharmacol. 2011 Jan 15 650 2-3 673-81

Download in:

View as

General Info

PMID
20974124